Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluate the Safety, Immunogenicity and Potential Efficacy of an rVSV-SARS-CoV-2-S Vaccine

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04608305
Recruitment Status : Recruiting
First Posted : October 29, 2020
Last Update Posted : April 27, 2021
Sponsor:
Information provided by (Responsible Party):
Israel Institute for Biological Research (IIBR)

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : May 1, 2021
Estimated Study Completion Date : June 1, 2022